A long-term study on the effect of pindolol on serum lipoproteins: a preliminary report.
1. Preliminary results are reported from a long-term study aimed at recording the concentrations of serum lipids and lipoproteins at 6, 12 and 24 months of treatment with pindolol in young/middle-aged males with moderate hypertension. 2. Seventy-three patients have been recruited, of whom 47 have completed 6 months treatment. After 6 months treatment 35/47 patients had attained the target blood pressure of less than or equal to 95 mm Hg and analysis of plasma lipid and lipoprotein concentrations revealed a tendency for an increase of serum triglycerides and a lowering of low density lipoprotein cholesterol.
King Gustaf V Research Institute, Department of Internal Medicine, Karolinska Hospital, Stockholm.
L A
LA
Carlson
M
M
Ribacke
A
A
Terent
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000009:adverse effects* / Q000627:therapeutic use
D008074:Lipoproteins; D010869:Pindolol